Welcome to our dedicated page for Prestige Consmr Healthcare news (Ticker: PBH), a resource for investors and traders seeking the latest updates and insights on Prestige Consmr Healthcare stock.
The PBH news page on Stock Titan tracks announcements and disclosures from Prestige Consumer Healthcare Inc., a consumer healthcare products company listed on the New York Stock Exchange. Prestige issues frequent press releases covering its over-the-counter (OTC) brand portfolio, financial performance and corporate activities across the U.S. and Canada, Australia, and certain other international markets.
Investors and observers can use this news feed to follow quarterly and annual earnings releases, where Prestige reports revenues, net income, earnings per share, free cash flow, leverage and segment results for its North American OTC Healthcare and International OTC Healthcare businesses. These updates often highlight category trends such as gastrointestinal, women’s health, cough and cold, and eye and ear care, as well as the performance of brands including Monistat®, Summer’s Eve®, Clear Eyes®, Dramamine®, Fleet®, Hydralyte® and others.
The PBH news stream also includes announcements about investor conference participation, such as presentations at consumer staples and consumer growth and e-commerce conferences, and notices of upcoming earnings calls with webcast details. Corporate actions and regulatory topics appear as well, including the voluntary recall by Medtech Products Inc., a Prestige company, of specific lots of Little Remedies® Honey Cough Syrup due to microbial contamination, and communications about strategic transactions like the planned acquisition of Pillar5 Pharma Inc., a sterile ophthalmic manufacturer and Clear Eyes® supplier.
By reviewing the PBH news page regularly, readers can see how Prestige describes its business priorities, category performance, capital allocation decisions such as share repurchases, and developments affecting its OTC healthcare brands and supply chain.
Prestige Consumer Healthcare announced its fiscal 2025 first quarter earnings release will be issued on August 8, 2024, before the market opens.
The company will host a conference call to discuss the results at 8:30 a.m. ET the same day. Participants can join the live Internet webcast via the Investor Relations page on the company's website. Phone participants need to register to receive dial-in details and a unique pin. It is recommended to join the call 10 minutes early. A replay of the conference call will be available for a week on the Investor Relations page.
Prestige Consumer Healthcare (NYSE:PBH) will present at the Oppenheimer Annual Consumer Growth and E-Commerce Conference on June 10, 2024, at 1:30 p.m. ET. Interested parties can access a live webcast of the event via the company's website under the 'Investors' section or use the provided link. A replay will be available for those unable to attend the live session.
Prestige Consumer Healthcare (NYSE: PBH) reported its fiscal year 2024 results with $277.0 million in Q4 revenue and $1,125.4 million for the full year, a slight 0.2% increase from the previous year. Q4 net income was $49.5 million, a significant improvement from the previous year's net loss of $240.6 million. The company's leverage ratio was reduced to 2.8x, below its long-term target. The Board authorized a new $300 million share repurchase program. For fiscal 2025, Prestige anticipates a 1% organic revenue growth and an EPS range of $4.40 to $4.46. Ongoing supply chain issues, particularly in eye care products, affected Q4 performance but are expected to improve mid-2025.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.